Lemaitre Vascular Inc - Current report filing (8-K)
July 31 2008 - 6:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): 07/29/2008
LeMaitre Vascular, Inc.
(Exact name of registrant as specified in its
charter)
Commission File Number: 001-33092
|
|
|
Delaware
|
|
04-2825458
|
(State or other jurisdiction
of incorporation)
|
|
(IRS Employer
Identification No.)
|
63 Second Avenue
Burlington, MA 01803
(Address of principal executive offices, including zip
code)
781-221-2266
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Information to be included in the report
Item 2.02. Results of Operations and Financial Condition
On July 29, 2008, LeMaitre Vascular, Inc. issued a press
release regarding its financial and operational results for the second quarter ended June 30, 2008. A copy of the press release is furnished as Exhibit 99.1 to this report.
The information in this report, including the Exhibit attached hereto, is intended to be furnished and shall not be deemed filed for purposes
of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the
Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits
The following exhibit is furnished as part of this report, where indicated:
(d) Exhibits.
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press release issued by LeMaitre Vascular, Inc. on July 29, 2008, announcing its financial and operational results for the second quarter ended June 30, 2008, furnished
herewith.
|
Signature(s)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
LeMaitre Vascular, Inc.
|
|
|
|
|
Date: July 30, 2008
|
|
|
|
By:
|
|
Aaron M. Grossman
/s/ Aaron M. Grossman
|
|
|
|
|
|
|
Aaron M. Grossman
Secretary
|
Exhibit Index
|
|
|
Exhibit No.
|
|
Description
|
|
|
EX-99.1
|
|
Press Release
|
LeMaitre Vascular (NASDAQ:LMAT)
Historical Stock Chart
From Jul 2024 to Jul 2024
LeMaitre Vascular (NASDAQ:LMAT)
Historical Stock Chart
From Jul 2023 to Jul 2024